Table 2 Main outcome variables
From: Effect of dextran-70 on outcome in severe sepsis; a propensity-score matching study
| Â | Propensity-matched groups | Relative risk (95% CI) | Absolute risk reduction (95% CI) | Pa | |
|---|---|---|---|---|---|
Outcome | Control n = 245 | Dextran n = 245 |  |  |  |
AKIN maxb median (Q1-Q3c) | 1 (0–3) | 2 (0–3) |  |  | 0.06 |
DAFd of RRT, median (Q1-Q3) | 28 (0–28) | 28 (0–28) |  |  | 0.52 |
DAF of vasopressors, median (Q1-Q3) | 25 (0–27) | 24 (0–26) |  |  | 0.96 |
DAF of mechanical ventilation, median (Q1-Q3) | 24 (0–28) | 22 (0–27) |  |  | 0.44 |
RRTe, no (%) | 46 (18.8) | 53 (21.6) | 1.15 (0.81 to 1.64) | −2.9% (−9.9 to 4.2%) | 0.42 |
Bleeding episodesf, no (%) | 35 (14) | 45 (18) | 1.29 (0.86 to 1.93) | −4.1% (−10.6 to 2.5%) | 0.21 |
28-day mortality, no (%) | 86 (35.1) | 78 (31.8) | 0.91 (0.71 to 1.17) | 3.3% (−5.1 to 11.7%) | 0.41 |
90-day mortality, no (%) | 109 (44.5) | 96 (39.2) | 0.88 (0.71 to 1.08) | 5.3% (−3.4 to 14.0%) | 0.21 |
180-day mortality, no (%) | 123 (50.2) | 102 (41.6) | 0.83 (0.68 to 1.01) | 8.6% (−0.2 to 17.4%) | 0.046 |